The U.S. Food and Drug Administration has declined to approve an injectable version of Johnson & Johnson's drug Rybrevant for ...

Teos Therapeutics has potential lung cancer treatment despite issues and strong financial position. Read here to know why we ...

The FDA granted breakthrough therapy designation to sacituzumab govitecan for patients with ES-SCLC progressing on platinum ...

Discover the latest advancements in small cell lung cancer through Novotech CRO’s in-depth disease analysis. Gain valuable insights into novel therapies, ongoing clinical trials, and future ...

The FDA issues a complete response letter to JNJ's BLA seeking approval for the subcutaneous formulation of Rybrevant in EGFR ...

China National Medical Products Administration (NMPA) has approved MSD’s KEYTRUDA for treating certain non-small cell lung cancer (NSCLC).

Researchers have used a chemical compound to light up treatment-resistant cancers on imaging scans, in a breakthrough that ...

Angelica Campbell said her daughter, Eliza, had a "horrendous" start to her life after she was diagnosed with an aggressive ...

The US regulator has turned down J&J's marketing application for a subcutaneous (SC) formulation of EGFRxMET bispecific ...

Jazz Pharmaceuticals announced that the FDA has approved ZIIHERA® (zanidatamab-hrii) on an accelerated basis for the treatment ...

The spirometer (built-in 1846 by Hutchinson) measures ventilatory function (dynamic lung volumes and maximal flow rates). Miller 1996 [1]) shows a normal spirogram showing the measurements of forced ...